Mucosal response of inactivated and recombinant COVID-19 vaccines in Congolese individuals.

Freisnel H MouzingaConstanze HeinzelAbel LissomAndrea KreidenweissArmel L Batchi-BouyouJacques D Mbama NtabiJean C DjontuEtienne NgumbiPeter G KremsnerRolf FendelFrancine Ntoumi

Published in: Immunity, inflammation and disease (2024)

Inactivated and recombinant COVID-19 vaccines in use in the Republic of Congo poorly activated mucosal IgA-mediated antibody response 2 months postvaccination.

Keyphrases

coronavirus disease
sars cov
ulcerative colitis
cell free